Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Feb;46(2):169–170. doi: 10.1136/jcp.46.2.169

p53 expression in dyskeratosis congenita: a marker for oral premalignancy?

G R Ogden 1, D P Lane 1, D M Chisholm 1
PMCID: PMC501151  PMID: 8459038

Abstract

As p53 expression has been associated with malignant disease its presence was assessed in biopsy specimens from dorsal lingual hyperkeratosis, taken over a five year period. p53 expression, using CM1, was assessed using a standard immunoperoxidase technique. p53 was not identified in the first biopsy specimen in 1986 but was identified in all subsequent ones. Only in the latest biopsy specimen was there evidence for dysplasia in haematoxylin and eosin stained sections. It is suggested that p53 expression may be a reliable marker for predicting premalignant change in keratoses occurring in dyskeratosis congenita.

Full text

PDF
170

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hall P. A., Ray A., Lemoine N. R., Midgley C. A., Krausz T., Lane D. P. p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet. 1991 Aug 24;338(8765):513–513. doi: 10.1016/0140-6736(91)90586-e. [DOI] [PubMed] [Google Scholar]
  2. Midgley C. A., Fisher C. J., Bártek J., Vojtesek B., Lane D., Barnes D. M. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci. 1992 Jan;101(Pt 1):183–189. doi: 10.1242/jcs.101.1.183. [DOI] [PubMed] [Google Scholar]
  3. Morgan P. R., Shirlaw P. J., Johnson N. W., Leigh I. M., Lane E. B. Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol. 1987 Apr;16(4):212–222. doi: 10.1111/j.1600-0714.1987.tb02068.x. [DOI] [PubMed] [Google Scholar]
  4. Ogden G. R., Chisholm D. M., Kiddie R. A., Lane D. P. p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol. 1992 Nov;45(11):1007–1010. doi: 10.1136/jcp.45.11.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ogden G. R., Chisholm D. M., Leigh I. M., Lane E. B. Cytokeratin profiles in dyskeratosis congenita: an immunocytochemical investigation of lingual hyperkeratosis. J Oral Pathol Med. 1992 Sep;21(8):353–357. doi: 10.1111/j.1600-0714.1992.tb01364.x. [DOI] [PubMed] [Google Scholar]
  6. Ogden G. R., Connor E., Chisholm D. M. Dyskeratosis congenita: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol. 1988 May;65(5):586–591. doi: 10.1016/0030-4220(88)90142-9. [DOI] [PubMed] [Google Scholar]
  7. Ogden G. R., Kiddie R. A., Lunny D. P., Lane D. P. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol. 1992 Apr;166(4):389–394. doi: 10.1002/path.1711660411. [DOI] [PubMed] [Google Scholar]
  8. Wynford-Thomas D. P53 in tumour pathology: can we trust immunocytochemistry? J Pathol. 1992 Apr;166(4):329–330. doi: 10.1002/path.1711660402. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES